Does Argus HQ track new FDA actions for Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles is observed, this page's event count and history update automatically.

How many FDA actions does Argus HQ track for Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles?

1 total: 0 warning letters, 1 recall, 0 approval records, and 0 Form 483 inspection citations.

What is the most recent FDA action on file for Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles?

May 13, 2026. Argus HQ ingests new FDA enforcement records daily.

Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles — FDA Enforcement History

FDA action counts

Total FDA actions	1
Warning letters	0
Recalls	1
Approval records	0
Form 483 inspection citations	0
Most recent action	May 13, 2026

Key takeaway: Argus HQ has recorded 1 FDA events for Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles: 0 warning letters, 1 recalls, 0 approvals, and 0 inspection 483 observations. These events span from 2026-05-13 to 2026-05-13. The most severe rating Argus HQ has assigned across this history is "high". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Enforcement history

On 2026-05-13, Argus HQ recorded an FDA recall for Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles, rated "high" severity in Argus HQ's classification: Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles — Class II recall: TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag,…. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Frequently asked questions

Does Argus HQ track new FDA actions for Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles automatically?: Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles is observed, this page's event count and history update automatically.
How many FDA actions does Argus HQ track for Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles?: 1 total: 0 warning letters, 1 recall, 0 approval records, and 0 Form 483 inspection citations.
What is the most recent FDA action on file for Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles?: May 13, 2026. Argus HQ ingests new FDA enforcement records daily.
Has Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles had product recalls?: Yes, 1 recall on file. See the full history below for each one.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles — Class II recall: TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag,… →

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Central Admixture Pharmacy Services, Inc (CAPS)  Los Angeles — FDA Enforcement History. Digital Empire LLC. Retrieved from https://argushq.ai/company/central-admixture-pharmacy-services-inc-caps-los-angeles

MLA

"Central Admixture Pharmacy Services, Inc (CAPS)  Los Angeles — FDA Enforcement History." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/company/central-admixture-pharmacy-services-inc-caps-los-angeles.

Chicago

Argus HQ Research. "Central Admixture Pharmacy Services, Inc (CAPS)  Los Angeles — FDA Enforcement History." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/company/central-admixture-pharmacy-services-inc-caps-los-angeles.

BibTeX

@misc{argushq_argushq_ai_company_central_admixture_pharmacy_services_inc_caps_los_angeles_2026,
  title = {Central Admixture Pharmacy Services, Inc (CAPS)  Los Angeles — FDA Enforcement History},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire LLC},
  url = {https://argushq.ai/company/central-admixture-pharmacy-services-inc-caps-los-angeles},
  note = {Accessed: July 13, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗